Australia’s trusted immunisation experts
23 October 2025 | NewsPacific island countries and Japan achieve measles and rubella elimination: a milestone for regional health securityRead the full article
Coversheet on evidence assessment: CVD 103–HgR (Vaxchora) in children and adults
Use of CVD 103–HgR (Vaxchora) cholera vaccine compared to placebo in children and adults aged ≥2 years who have a high risk of exposure to cholera
Compared to placebo in children and adults aged ≥2 years who have a high risk of exposure to cholera
Note: These GRADE documents should be read as a supplement to Australian Immunisation Handbook recommendations.
View the cholera disease chapter in the Australian Immunisation Handbook